TY - JOUR AU - Katzenschlager, R. PY - 2014 DA - 2014// TI - Parkinson’s disease: recent advances JO - J Neurol VL - 261 UR - https://doi.org/10.1007/s00415-014-7308-9 DO - 10.1007/s00415-014-7308-9 ID - Katzenschlager2014 ER - TY - JOUR AU - Chu, S. H. AU - Kim, E. J. AU - Jeong, S. H. AU - Park, G. L. PY - 2015 DA - 2015// TI - Factors associated with willingness to participate in clinical trials: a nationwide survey study JO - BMC Public Health VL - 15 UR - https://doi.org/10.1186/s12889-014-1339-0 DO - 10.1186/s12889-014-1339-0 ID - Chu2015 ER - TY - JOUR AU - Ohmann, C. AU - Deimling, A. PY - 2004 DA - 2004// TI - Attitude towards clinical trials: results of a survey of persons interested in research JO - Inflamm Res VL - 53 ID - Ohmann2004 ER - TY - JOUR AU - Comis, R. L. AU - Miller, J. D. AU - Aldige, C. R. AU - Krebs, L. AU - Stoval, E. PY - 2003 DA - 2003// TI - Public attitudes toward participation in cancer clinical trials JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.02.105 DO - 10.1200/JCO.2003.02.105 ID - Comis2003 ER - TY - JOUR AU - Madsen, S. AU - Holm, S. AU - Riis, P. PY - 1999 DA - 1999// TI - Ethical aspects of clinical trials: the attitudes of the public and out-patients JO - J Intern Med VL - 245 UR - https://doi.org/10.1046/j.1365-2796.1999.00502.x DO - 10.1046/j.1365-2796.1999.00502.x ID - Madsen1999 ER - TY - JOUR AU - McCann, S. K. AU - Campbell, M. K. AU - Entwistle, V. A. PY - 2010 DA - 2010// TI - Reasons for participating in randomised controlled trials: conditional altruism and considerations for self JO - Trials VL - 11 UR - https://doi.org/10.1186/1745-6215-11-31 DO - 10.1186/1745-6215-11-31 ID - McCann2010 ER - TY - JOUR AU - Valadas, A. AU - Coelho, M. AU - Mestre, T. AU - Guedes, L. C. AU - Finisterra, M. AU - Noronha, A. PY - 2011 DA - 2011// TI - What motivates Parkinson’s disease patients to enter clinical trials? JO - Parkinsonism Relat Disord VL - 17 UR - https://doi.org/10.1016/j.parkreldis.2011.05.023 DO - 10.1016/j.parkreldis.2011.05.023 ID - Valadas2011 ER - TY - JOUR AU - Goetz, C. G. AU - Janko, K. AU - Blasucci, L. AU - Jaglin, J. A. PY - 2003 DA - 2003// TI - Impact of placebo assignment in clinical trials of Parkinson’s disease JO - Mov Disord VL - 18 UR - https://doi.org/10.1002/mds.10504 DO - 10.1002/mds.10504 ID - Goetz2003 ER - TY - JOUR AU - Finder, S. G. AU - Bliton, M. J. AU - Gill, C. E. AU - Davis, T. L. AU - Konrad, P. E. AU - Charles, P. D. PY - 2012 DA - 2012// TI - Potential subjects’ responses to an ethics questionnaire in a phase I study of deep brain stimulation in early Parkinson’s disease JO - J Clin Ethics VL - 23 ID - Finder2012 ER - TY - JOUR AU - Mathur, S. AU - DeWitte, S. AU - Robledo, I. AU - Isaacs, T. AU - Stamford, J. PY - 2015 DA - 2015// TI - Rising to the challenges of clinical trial improvement in Parkinson’s disease JO - J Parkinsons Dis VL - 5 UR - https://doi.org/10.3233/JPD-150541 DO - 10.3233/JPD-150541 ID - Mathur2015 ER - TY - JOUR AU - Reijula, E. AU - Halkoaho, A. AU - Pietila, A. M. AU - Selander, T. AU - Kalviainen, R. AU - Keranen, T. PY - 2015 DA - 2015// TI - Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling JO - Epilepsy Behav VL - 48 UR - https://doi.org/10.1016/j.yebeh.2015.05.013 DO - 10.1016/j.yebeh.2015.05.013 ID - Reijula2015 ER - TY - JOUR AU - Halkoaho, A. PY - 2012 DA - 2012// TI - Ethical aspects of human tissue research views of the stakeholders JO - Publ Univ East Finl Diss Health Sci VL - 102 ID - Halkoaho2012 ER - TY - JOUR AU - Chou, P. H. AU - O’Rourke, N. PY - 2012 DA - 2012// TI - Development and initial validation of the Therapeutic Misunderstanding Scale for use with clinical trials research participants JO - Aging Ment Health VL - 16 UR - https://doi.org/10.1080/13607863.2011.602962 DO - 10.1080/13607863.2011.602962 ID - Chou2012 ER - TY - JOUR AU - Jenkinson, C. AU - Burton, J. S. AU - Cartwright, J. AU - Magee, H. AU - Hall, I. AU - Alcock, C. PY - 2005 DA - 2005// TI - Patient attitudes to clinical trials: development of a questionnaire and results from asthma and cancer patients JO - Health Expect VL - 8 UR - https://doi.org/10.1111/j.1369-7625.2005.00335.x DO - 10.1111/j.1369-7625.2005.00335.x ID - Jenkinson2005 ER - TY - JOUR AU - Ravina, B. AU - Swearingen, C. AU - Elm, J. AU - Kamp, C. AU - Kieburtz, K. AU - Kim, S. Y. PY - 2010 DA - 2010// TI - Long term understanding of study information in research participants with Parkinson’s disease JO - Parkinsonism Relat Disord VL - 16 UR - https://doi.org/10.1016/j.parkreldis.2009.05.007 DO - 10.1016/j.parkreldis.2009.05.007 ID - Ravina2010 ER - TY - JOUR AU - Kim, S. Y. AU - Vries, R. AU - Parnami, S. AU - Wilson, R. AU - Kim, H. M. AU - Frank, S. PY - 2015 DA - 2015// TI - Are therapeutic motivation and having one’s own doctor as researcher sources of therapeutic misconception? JO - J Med Ethics VL - 41 UR - https://doi.org/10.1136/medethics-2013-101987 DO - 10.1136/medethics-2013-101987 ID - Kim2015 ER - TY - JOUR AU - Kim, S. Y. AU - Vries, R. AU - Holloway, R. G. AU - Wilson, R. AU - Parnami, S. AU - Kim, H. M. PY - 2012 DA - 2012// TI - Sham surgery controls in Parkinson’s disease clinical trials: views of participants JO - Mov Disord VL - 27 UR - https://doi.org/10.1002/mds.25155 DO - 10.1002/mds.25155 ID - Kim2012 ER - TY - JOUR AU - Burns, K. E. AU - Magyarody, N. AU - Jiang, D. AU - Wald, R. PY - 2013 DA - 2013// TI - Attitudes and views of the general public towards research participation JO - Intern Med J VL - 43 UR - https://doi.org/10.1111/j.1445-5994.2011.02433.x DO - 10.1111/j.1445-5994.2011.02433.x ID - Burns2013 ER - TY - JOUR AU - Ellis, P. M. AU - Dowsett, S. M. AU - Butow, P. N. AU - Tattersall, M. H. PY - 1999 DA - 1999// TI - Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic JO - Health Expect VL - 2 UR - https://doi.org/10.1046/j.1369-6513.1999.00028.x DO - 10.1046/j.1369-6513.1999.00028.x ID - Ellis1999 ER - TY - JOUR AU - Madsen, S. M. AU - Mirza, M. R. AU - Holm, S. AU - Hilsted, K. L. AU - Kampmann, K. AU - Riis, P. PY - 2002 DA - 2002// TI - Attitudes towards clinical research amongst participants and nonparticipants JO - J Intern Med VL - 251 UR - https://doi.org/10.1046/j.1365-2796.2002.00949.x DO - 10.1046/j.1365-2796.2002.00949.x ID - Madsen2002 ER - TY - JOUR AU - Locock, L. AU - Smith, L. PY - 2011 DA - 2011// TI - Personal benefit, or benefiting others? Deciding whether to take part in clinical trials JO - Clin Trials VL - 8 UR - https://doi.org/10.1177/1740774510392257 DO - 10.1177/1740774510392257 ID - Locock2011 ER - TY - JOUR AU - Hietanen, P. AU - Aro, A. R. AU - Holli, K. AU - Absetz, P. PY - 2000 DA - 2000// TI - Information and communication in the context of a clinical trial JO - Eur J Cancer VL - 36 UR - https://doi.org/10.1016/S0959-8049(00)00191-X DO - 10.1016/S0959-8049(00)00191-X ID - Hietanen2000 ER - TY - JOUR AU - Welton, A. J. AU - Vickers, M. R. AU - Cooper, J. A. AU - Meade, T. W. AU - Marteau, T. M. PY - 1999 DA - 1999// TI - Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study JO - BMJ VL - 318 UR - https://doi.org/10.1136/bmj.318.7191.1114 DO - 10.1136/bmj.318.7191.1114 ID - Welton1999 ER - TY - JOUR AU - Agoritsas, T. AU - Deom, M. AU - Perneger, T. V. PY - 2011 DA - 2011// TI - Study design attributes influenced patients’ willingness to participate in clinical research: a randomized vignette-based study JO - J Clin Epidemiol VL - 64 UR - https://doi.org/10.1016/j.jclinepi.2010.02.007 DO - 10.1016/j.jclinepi.2010.02.007 ID - Agoritsas2011 ER - TY - JOUR AU - Appelbaum, P. S. PY - 2016 DA - 2016// TI - How not to test the prevalence of therapeutic misconception JO - J Med Ethics VL - 42 UR - https://doi.org/10.1136/medethics-2016-103466 DO - 10.1136/medethics-2016-103466 ID - Appelbaum2016 ER - TY - JOUR AU - Kim, S. Y. AU - Vries, R. AU - Holloway, R. G. AU - Kieburtz, K. PY - 2016 DA - 2016// TI - Understanding the “therapeutic misconception” from the research participant’s perspective JO - J Med Ethics VL - 42 UR - https://doi.org/10.1136/medethics-2016-103597 DO - 10.1136/medethics-2016-103597 ID - Kim2016 ER - TY - JOUR AU - Appelbaum, P. S. AU - Lidz, C. W. AU - Grisso, T. PY - 2004 DA - 2004// TI - Therapeutic misconception in clinical research: frequency and risk factors JO - IRB VL - 26 UR - https://doi.org/10.2307/3564231 DO - 10.2307/3564231 ID - Appelbaum2004 ER - TY - JOUR AU - Henderson, G. E. AU - Churchill, L. R. AU - Davis, A. M. AU - Easter, M. M. AU - Grady, C. AU - Joffe, S. PY - 2007 DA - 2007// TI - Clinical trials and medical care: defining the therapeutic misconception JO - PLoS Med VL - 4 UR - https://doi.org/10.1371/journal.pmed.0040324 DO - 10.1371/journal.pmed.0040324 ID - Henderson2007 ER - TY - JOUR AU - Hallowell, N. AU - Snowdon, C. AU - Morrow, S. AU - Norman, J. E. AU - Denison, F. C. AU - Lawton, J. PY - 2016 DA - 2016// TI - The role of therapeutic optimism in recruitment to a clinical trial in a peripartum setting: balancing hope and uncertainty JO - Trials VL - 17 UR - https://doi.org/10.1186/s13063-016-1394-1 DO - 10.1186/s13063-016-1394-1 ID - Hallowell2016 ER - TY - JOUR AU - Sulmasy, D. P. AU - Astrow, A. B. AU - He, M. K. AU - Seils, D. M. AU - Meropol, N. J. AU - Micco, E. PY - 2010 DA - 2010// TI - The culture of faith and hope: patients’ justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25201 DO - 10.1002/cncr.25201 ID - Sulmasy2010 ER - TY - JOUR AU - Jansen, L. A. PY - 2011 DA - 2011// TI - Two concepts of therapeutic optimism JO - J Med Ethics VL - 37 UR - https://doi.org/10.1136/jme.2010.038943 DO - 10.1136/jme.2010.038943 ID - Jansen2011 ER - TY - JOUR AU - Lyons, B. PY - 2016 DA - 2016// TI - Faith, hope and (no) clarity JO - J Med Ethics VL - 42 UR - https://doi.org/10.1136/medethics-2016-103807 DO - 10.1136/medethics-2016-103807 ID - Lyons2016 ER - TY - JOUR AU - Lidz, C. W. AU - Appelbaum, P. S. AU - Grisso, T. AU - Renaud, M. PY - 2004 DA - 2004// TI - Therapeutic misconception and the appreciation of risks in clinical trials JO - Soc Sci Med VL - 58 UR - https://doi.org/10.1016/S0277-9536(03)00338-1 DO - 10.1016/S0277-9536(03)00338-1 ID - Lidz2004 ER - TY - JOUR AU - Durand-Zaleski, I. S. AU - Alberti, C. AU - Durieux, P. AU - Duval, X. AU - Gottot, S. AU - Ravaud, P. PY - 2008 DA - 2008// TI - Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception JO - J Med Ethics VL - 34 UR - https://doi.org/10.1136/jme.2007.023473 DO - 10.1136/jme.2007.023473 ID - Durand-Zaleski2008 ER - TY - JOUR AU - Mansour, H. AU - Zaki, N. AU - Abdelhai, R. AU - Sabry, N. AU - Silverman, H. AU - El-Kamary, S. S. PY - 2015 DA - 2015// TI - Investigating the informed consent process, therapeutic misconception and motivations of Egyptian research participants: a qualitative pilot study JO - East Mediterr Health J VL - 21 ID - Mansour2015 ER - TY - JOUR AU - Kim, S. Y. AU - Wilson, R. AU - Vries, R. AU - Kim, H. M. AU - Holloway, R. G. AU - Kieburtz, K. PY - 2015 DA - 2015// TI - Could the high prevalence of therapeutic misconception partly be a measurement problem? JO - IRB VL - 37 ID - Kim2015 ER - TY - JOUR AU - Kim, S. Y. AU - Wilson, R. AU - Vries, R. AU - Ryan, K. A. AU - Holloway, R. G. AU - Kieburtz, K. PY - 2016 DA - 2016// TI - Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception? JO - J Med Ethics VL - 42 UR - https://doi.org/10.1136/medethics-2015-103319 DO - 10.1136/medethics-2015-103319 ID - Kim2016 ER - TY - JOUR AU - Appelbaum, P. S. AU - Anatchkova, M. AU - Albert, K. AU - Dunn, L. B. AU - Lidz, C. W. PY - 2012 DA - 2012// TI - Therapeutic misconception in research subjects: development and validation of a measure JO - Clin Trials VL - 9 UR - https://doi.org/10.1177/1740774512456455 DO - 10.1177/1740774512456455 ID - Appelbaum2012 ER - TY - JOUR AU - Marttila, R. J. AU - Rinne, U. K. PY - 1979 DA - 1979// TI - Changing epidemiology of Parkinson’s disease: predicted effects of levodopa treatment JO - Acta Neurol Scand VL - 59 UR - https://doi.org/10.1111/j.1600-0404.1979.tb02914.x DO - 10.1111/j.1600-0404.1979.tb02914.x ID - Marttila1979 ER - TY - JOUR AU - Kuopio, A. M. AU - Marttila, R. J. AU - Helenius, H. AU - Rinne, U. K. PY - 1999 DA - 1999// TI - Changing epidemiology of Parkinson’s disease in southwestern Finland JO - Neurology VL - 52 UR - https://doi.org/10.1212/WNL.52.2.302 DO - 10.1212/WNL.52.2.302 ID - Kuopio1999 ER - TY - JOUR AU - Eeden, S. K. AU - Tanner, C. M. AU - Bernstein, A. L. AU - Fross, R. D. AU - Leimpeter, A. AU - Bloch, D. A. PY - 2003 DA - 2003// TI - Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity JO - Am J Epidemiol VL - 157 UR - https://doi.org/10.1093/aje/kwg068 DO - 10.1093/aje/kwg068 ID - Eeden2003 ER - TY - JOUR AU - Havulinna, A. S. AU - Tienari, P. J. AU - Marttila, R. J. AU - Martikainen, K. K. AU - Eriksson, J. G. AU - Taskinen, O. PY - 2008 DA - 2008// TI - Geographical variation of medicated parkinsonism in Finland during 1995 to 2000 JO - Mov Disord VL - 23 UR - https://doi.org/10.1002/mds.22024 DO - 10.1002/mds.22024 ID - Havulinna2008 ER - TY - JOUR AU - Rijk, M. C. AU - Tzourio, C. AU - Breteler, M. M. AU - Dartigues, J. F. AU - Amaducci, L. AU - Lopez-Pousa, S. PY - 1997 DA - 1997// TI - Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease JO - J Neurol Neurosurg Psychiatry VL - 62 UR - https://doi.org/10.1136/jnnp.62.1.10 DO - 10.1136/jnnp.62.1.10 ID - Rijk1997 ER -